Background: Traumatic brain injury (TBI) is one of the leading causes that cognitive and behavioral problems. Many pharmacological therapies reveal early neurochemical changes. The CRS-R is a standardized neuro-behavioral evaluation tool comprising six organized subscales (auditory, visual, motor, oromotor-verbal, communication, and arousal). We hypothesized that, the effect of amantadine sulfate infusion treatment on conscious recovery and clinical improvement in patients with severe head injury in terms of CRS-R and clinical recovery. Methods: Patients' age, gender, days of hospitalization, pre-treatment and post-treatment GCS, education level, day of amantadine sulfate, intubated or non-intubated when he/she come to ICU, recovery time of conscious, discharge time, CT or MR pathology will be retrospectively recorded. Patients were aged >18, had brain trauma, had amantadine sulfate therapy in ICU were included the study between June 2016-June 2017. Results: A total of 40 patients using amantadine sulfate infusion were included in the study. It was determined that 13 of patients had mortality. Improvement in CT and MRI findings were detected in 21 of the living patients (77.8%). There were no differences between the mean starting time according to the clinical recovery levels and recovery status on CT-MRI. There were statistically significant differences between starting time and time of extubation and starting time of consciousness recovery and discharge time. Conclusion: In conclusion, we believe that amantadine treatment accelerates neurological recovery in terms of CRS-R and clinical recovery in TBI patients.
Keywords: Amantadine sulfate; cerebral injury; traumatic brain injury
Amaç: Travmatik beyin hasarı (TBH), bilişsel ve davranışsal sorunların önde gelen nedenlerinden biridir. Birçok farmakolojik tedavi erken nörokimyasal değişiklikleri açıklamaktadır. CRS-R, altı organize alt ölçek (işitsel, görsel, motor, oromotor-sözel, iletişim ve uyarılma) içeren standartlaştırılmış bir nöro davranışsal değerlendirme aracıdır. Biz CRS-R ve klinik iyileşme açısından ağır kafa travmalı hastalarda amantadin sülfat infüzyon tedavisinin bilinç düzeyinde ve klinik iyileşme üzerindeki etkisini sunmayı amaçladık. Gereç ve Yöntem: Hastaların yaşı, cinsiyeti, hastanede yatış günleri, tedavi öncesi ve tedavi sonrası GKS, eğitim düzeyi, amantadin sülfat günü, entübe gelip gelmediği, bilinçte düzelme zamanı, taburculuk süresi, BT veya MR patolojileri retrospektif olarak kaydedildi. Haziran-Haziran 2017 tarihleri arasında 18 yaş üstü, beyin travması geçiren, yoğun bakımda amantadin sülfat tedavisi alan hastalar çalışmaya dahil edildi. Bulgular: Çalışmaya amantadin sülfat infüzyonu kullanan toplam 40 hasta dahil edildi. Hastaların 13'ünde mortalite olduğu tespit edildi. Yaşayan hastaların 21'inde (% 77.8) BT ve MR bulgularında iyileşme saptandı. Klinik iyileşme düzeylerine ve BT-MR'da iyileşme durumuna göre ortalama başlangıç zamanı arasında fark yoktu. Başlangıç zamanı ve ekstübasyon zamanı ile bilincin düzelme ve taburculuk süresinin zamanı arasında istatistik olarak anlamlı fark gözlendi. Tartışma: Sonuç olarak, amantadin sülfat tedavisinin, CRS-R açısından da değerlendirildiğinde TBH hastalarında klinik iyileşme ve nörolojik iyileşmeyi hızlandırdığını düşünüyoruz.
Anahtar Kelimeler: Amantadin sülfat; serebral yaralanma; travmatik beyin hasarı
- Gramish JA, Kopp BJ, Patanwala AE. Effect of amantadine on agitation in critically Ill patients with traumatic brain injury. Clin Neuropharmacol. 2017;40(5):212-6. [Crossref] [PubMed]
- Saniova B, Drobny M, Kneslova L, Minarik M. The outcome of patients with severe head injuries treated with amantadine sulfate. J Neural Transm (Vienna). 2004;111(4):511-4. [Crossref] [PubMed]
- Giacino JT, Whyte J, Bagiella E, Kalmar K, Childs N, Khademi A, et al. Placebo-controlled trial of amantadine or severe traumatic brain injury. N Engl J Med. 2012;366(9):819-26. [Crossref] [PubMed]
- Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother. 2008;42(2):247-52. [Crossref] [PubMed]
- Bakay RA, Sweeney KM, Wood JH. Pathophysiology of cerebrospinal fluid in head injury: Part 1. Pathological changes in cerebrospinal fluid solute composition after traumatic injury. Neurosurgery. 1986;18(2):234-43. [Crossref] [PubMed]
- Meythaler JM, Peduzzi JD, Eleftheriou E, Novack TA. Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil. 2001;82(10):1461-71. [Crossref] [PubMed]
- Hamill RW, Woolf PD, McDaonald JV, Lee LA, Kelly M. Catecholamines predict outcome in traumatic brain injury. Ann Neurol. 1987;21(5):438-43. [Crossref] [PubMed]
- Jorg J, Ringendahl H, Ischebeck W, Baumann JL. Amantadine sulfate infusion in the treatment of vigilance and drive disorders. Nervenheilkunde. 2000;19(9):521-8.
- Nickels JL, Schneider WN, Dombovy ML, Wong TM. Clinical use of amantadine in brain injury rehabilitation. Brain Inj. 1994;8(8):709-18. [Crossref] [PubMed]
- Krivonos OV, Amasova NA, Smolentseva IG. Use of the glutamate NMDA receptor anatagonist PK-Merz in acute stroke. Neurosci Behav Physiol. 2010;40(5):529-32. [Crossref] [PubMed]
- Wu TS, Garmel GM. Improved neurological function after amantadine treatment in two patients with brain injury. J Emerg Med. 2005;28(3):289-92. [Crossref] [PubMed]
- Aksu NM, Senlikci H, Akkas M, Özmen MM. The neurological improvement of a patient after amantadine infusion. JAEMCR. 2013;4: 161-3. [Crossref]
- Tutal ZB, Ozayar E, Kenan I, Babayiğit M, Gökhaner MŞ, Horasanlı E. Neurological recovery after amantadine treatment in a patient with septic arthritis: a case report. J Turk Soc Intens Care. 2016;14(1):39-42.[Crossref]
- Steube D, Görtelmeyer R. The influence of amantadine sulfate on disturbances of arousal after severe traumatic brain injury. Neurol Rehabil. 2000;6(6):307-12.
- Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil. 2004;85(12):2020-9.[Crossref] [PubMed]
.: Process List